Seralutinib (PK-10571; GB-002) is a novel and potent PDGFRα/β inhibitor used as an inhaled formulation for the treatment of PAH (pulmonary arterial hypertension). Seralutinib exhibits high in vivo efficacy in a Su5416 Hypoxia Rat Model with PAH.

纯度：≥98%

CAS：1619931-27-9